Summary
Updated Aug 31, 2026
Holger Weis is CEO of Alaunos Therapeutics, Inc. (TCRT). 10 SEC Form 4 filings on record going back to 2025, most recently on 11 August 2026.
Recent Transactions
6Every recent SEC Form 4 transaction Holger Weis has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Holger Weis go back to 2025: 10 primary Form 4 filings, an average of 5.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Holger Weis. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christer Rosen - $12K of JUNS open-market activity on record
- Robert W. Postma - $5K of TCRT open-market activity on record
- Alison D. Silva - $3K of JUNS open-market activity on record
- Jaime Vieser - $1K of TCRT open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Holger Weis?
Holger Weis is a corporate insider, tracked as CEO of Alaunos Therapeutics, Inc. (TCRT). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Holger Weis submitted recently?
6 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Holger Weis's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Holger Weis and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial